Author: immunitoAI

Founded in 2020 by Dr. Aridni Shah (PhD in Biological Sciences, NCBS) and Trisha Chatterjee (MS Computer Science), immunitoAI was incubated at IIM Bangalore’s NSRCEL. The company pivoted from a broad “AI for Bio” approach to a specific “Drug-First” thesis. Unlike competitors who screen millions of molecules to find one that works (discovery), immunitoAI generates molecules with pre-defined drug properties (design). Early backing came from pi Ventures and Entrepreneur First. The company has moved from purely in silico (computer) predictions to establishing an in-house wet lab to validate results—a critical step that separates “PowerPoint bio” from clinical reality.